All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Mon 1984-11-05? to Fri 2025-01-17 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
GSK × |
−1.27%
2025-01-17 |
15.24 TRR
2025-01-17 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Fri 2025-01-17 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
GSK × |
+1,424.40%
+7.01%/yr |
+5.25%/yr
(R2=0.683) |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Fri 2025-01-17 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
GSK × |
$10,000.00
1984-11-05 |
$152,439.58
2025-01-17 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Year | GSK |
---|---|
2025 (YTD) | −1.27% |
2024 | −7.81% |
2023 | +6.16% |
2022 | −23.23% |
2021 | +18.33% |
2020 | −18.89% |
2019 | +26.24% |
2018 | +11.54% |
2017 | −5.07% |
2016 | −0.11% |
2015 | −1.07% |
2014 | −16.39% |
2013 | +26.89% |
2012 | −1.15% |
2011 | +18.95% |
2010 | −3.65% |
2009 | +16.05% |
2008 | −22.38% |
2007 | −4.76% |
2006 | +5.25% |
2005 | +6.16% |
2004 | +2.22% |
2003 | +26.27% |
2002 | −23.46% |
2001 | −11.02% |
2000 | +0.66% |
1999 | −20.09% |
1998 | +45.79% |
1997 | +53.15% |
1996 | +14.06% |
1995 | +41.54% |
1994 | +0.33% |
1993 | −12.91% |
1992 | −25.12% |
1991 | +92.97% |
1990 | +22.86% |
1989 | +32.50% |
1988 | +2.43% |
1987 | +15.34% |
1986 | +37.65% |
1985 | +68.43% |
1984 | −1.92% |
Mon 1984-11-05? to Fri 2025-01-17 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
GSK × | −30.00% |
−60.56%
2009-03-09 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||